Clinical Trial Update: Hepatic Monitoring for Pazopanib

View source ↗

Summary

Safety update on Pazopanib for renal cell carcinoma focusing on hepatic monitoring requirements. The document outlines liver function monitoring during treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Status: COMPLETED